Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 12 Jun 2008 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Kotak BSE Sensex ETF |
|---|---|
| 12 Jun 2008 | ₹100.00 |
| 18 Dec 2009 | ₹111.04 |
| 24 Jun 2011 | ₹122.75 |
| 29 Dec 2012 | ₹133.01 |
| 05 Jul 2014 | ₹174.76 |
| 10 Jan 2016 | ₹166.68 |
| 17 Jul 2017 | ₹213.26 |
| 21 Jan 2019 | ₹246.22 |
| 28 Jul 2020 | ₹262.94 |
| 01 Feb 2022 | ₹405.80 |
| 09 Aug 2023 | ₹463.31 |
| 12 Feb 2025 | ₹541.68 |
| 20 Aug 2026 | ₹560.61 |
| Metric | Kotak Mahindra NAV ₹85.14 Very High risk ★★☆☆☆ | Category median Other ETFs · 248 funds |
|---|---|---|
| -4.44% | +3.65% | |
| +7.10% | +10.51% | |
| +8.03% | +9.28% | |
| +11.45% | +11.93% | |
| +9.94% | +10.38% | |
| +5.99% | — | |
| +11.94% | +14.30% | |
| +12.15% | +13.74% | |
| +11.78% | +12.83% | |
| Risk | ||
| 13.25% | 15.45% | |
| 0.05 | 0.28 | |
| 0.06 | 0.41 | |
| -47.62% | -20.59% | |
| Nifty 50 | — | |
| -0.74% | +0.80% | |
| 0.99 | 1.00 | |
| 98.7% | 102.1% | |
| 103.4% | 96.4% | |
| 0.17% | 0.32% | |
| ₹24.22Cr | ₹137.31Cr | |
| None | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Devender Singhal | — | |
| 12 Jun 2008 | — | |
| 30 | — | |
| 63.5% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.